Faron Pharmaceuticals Oy (LON:FARN) Share Price Passes Above Fifty Day Moving Average – Time to Sell?

Faron Pharmaceuticals Oy (LON:FARN) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 177.48 ($2.29) and traded as high as GBX 190 ($2.45). Faron Pharmaceuticals Oy shares last traded at GBX 185 ($2.39), with a volume of 9,756 shares.

Faron Pharmaceuticals Oy Price Performance

The firm has a market capitalization of £260.99 million, a P/E ratio of -5.20 and a beta of 0.36. The company has a debt-to-equity ratio of 922.55, a quick ratio of 1.09 and a current ratio of 1.45. The business has a 50 day simple moving average of GBX 177.37 and a two-hundred day simple moving average of GBX 185.89.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.